CSJA:FRA
CSL ADR
€ २९.८०
arrow_downward
-१.९७%(-०.६०) 1D
नोभेम्बर ९, ०८:१५:५९ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
€ २९.८०
High
€ २९.८०
Low
€ २९.८०
Mkt. cap
९६.३५ अरब
Avg. vol.
१०.००
Volume
०.००
52-wk high
€ ४३.४०
52-wk low
€ १२.७०
No. of employees
२९ हजार
Open
€ २९.८०
High
€ २९.८०
Low
€ २९.८०
Mkt. cap
९६.३५ अरब
Avg. vol.
१०.००
Volume
०.००
52-wk high
€ ४३.४०
52-wk low
€ १२.७०
No. of employees
२९ हजार
News stories
From web sources and news partners
Kalkine
·
३ दिन पहिले
CSL Limited Buys Back 44,316 Shares on 6 November 2026 for A$8.93 Million
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees२९ हजार
Founded१९१६
Headquartersमेलबर्न, भिक्टोरिया, अष्ट्रेलिया
SectorHealth Care
Industry-
Websitecsl.com